These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 1896820)

  • 1. The multi-crossover model for classifying patients as responders to a given treatment.
    Larsen S; Farup P; Flaten O; Osnes M
    Scand J Gastroenterol; 1991 Jul; 26(7):763-70. PubMed ID: 1896820
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ranitidine for non-ulcer dyspepsia. A clinical study of the symptomatic effect of ranitidine and a classification and characterization of the responders to treatment.
    Farup PG; Larsen S; Ulshagen K; Osnes M
    Scand J Gastroenterol; 1991 Nov; 26(11):1209-16. PubMed ID: 1754859
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ranitidine effectively relieves symptoms in a subset of patients with functional dyspepsia.
    Farup PG; Wetterhus S; Osnes M; Ulshagen K
    Scand J Gastroenterol; 1997 Aug; 32(8):755-9. PubMed ID: 9282965
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The effect of cimetidine in non-ulcer dyspepsia. Experience with a multi-cross-over model.
    Kleveland PM; Larsen S; Sandvik L; Kristensen P; Johannessen T; Hafstad PE; Sandbakken P; Løge I; Fjøsne U; Petersen H
    Scand J Gastroenterol; 1985 Jan; 20(1):19-24. PubMed ID: 3887548
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Controlled trials in gastrodyspepsia: a methodological aspect.
    Petersen H; Larsen S; Sandvik L; Kleveland PM; Løge I; Sandbakken P; Hafstad PE; Kristensen P; Johannessen T; Fjøsne U
    Scand J Gastroenterol Suppl; 1985; 109():153-8. PubMed ID: 3895387
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical presentation and personality factors are predictors of the response to treatment in patients with functional dyspepsia; a randomized, double-blind placebo-controlled crossover study.
    Holtmann G; Kutscher SU; Haag S; Langkafel M; Heuft G; Neufang-Hueber J; Goebell H; Senf W; Talley NJ
    Dig Dis Sci; 2004 Apr; 49(4):672-9. PubMed ID: 15185877
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cisapride compared with ranitidine in the treatment of functional dyspepsia.
    Carvalhinhos A; Fidalgo P; Freire A; Matos L
    Eur J Gastroenterol Hepatol; 1995 May; 7(5):411-7. PubMed ID: 7614103
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cimetidine responders in non-ulcer dyspepsia.
    Johannessen T; Fjøsne U; Kleveland PM; Halvorsen T; Kristensen P; Løge I; Hafstad PE; Sandbakken P; Petersen H
    Scand J Gastroenterol; 1988 Apr; 23(3):327-36. PubMed ID: 3291085
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Experience with a multi crossover model in dyspepsia.
    Johannessen T; Fosstvedt D; Petersen H
    Scand J Gastroenterol Suppl; 1988; 147():33-7. PubMed ID: 3201142
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The symptomatic effect of 1-day treatment periods with cimetidine in dyspepsia. Combined results from randomized, controlled, single-subject trials.
    Johannessen T; Kristensen P; Petersen H; Fosstvedt D; Løge I; Kleveland PM; Dybdahl J
    Scand J Gastroenterol; 1991 Sep; 26(9):974-80. PubMed ID: 1947791
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Ranitidine therapeutically effective in functional dyspepsia with reflux-like symptoms].
    Jebbink HJ; Smout AJ; van Berge Henegouwen GP
    Ned Tijdschr Geneeskd; 1993 Aug; 137(35):1772-5. PubMed ID: 8371822
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A randomized trial comparing omeprazole, ranitidine, cisapride, or placebo in helicobacter pylori negative, primary care patients with dyspepsia: the CADET-HN Study.
    Veldhuyzen van Zanten SJ; Chiba N; Armstrong D; Barkun A; Thomson A; Smyth S; Escobedo S; Lee J; Sinclair P
    Am J Gastroenterol; 2005 Jul; 100(7):1477-88. PubMed ID: 15984968
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ranitidine in the treatment of non-ulcer dyspepsia. A placebo-controlled study in the Federal Republic of Germany.
    Müller P; Hotz J; Franz E; Simon B
    Arzneimittelforschung; 1994 Oct; 44(10):1130-2. PubMed ID: 7818586
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Symptomatic response to blocked and unblocked pentagastrin stimulation in functional dyspepsia. Comparison of responders and non-responders to omeprazole identified in a single-subject trial model.
    Madsen LG; Bytzer P
    Dig Dis; 2008; 26(3):237-42. PubMed ID: 18463442
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Novel Augmentation Strategies in Major Depression.
    Martiny K
    Dan Med J; 2017 Apr; 64(4):. PubMed ID: 28385173
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Short course acid suppressive treatment for patients with functional dyspepsia: results depend on Helicobacter pylori status. The Frosch Study Group.
    Blum AL; Arnold R; Stolte M; Fischer M; Koelz HR
    Gut; 2000 Oct; 47(4):473-80. PubMed ID: 10986206
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Efficacy and tolerability of myrtol standardized in acute bronchitis. A multi-centre, randomised, double-blind, placebo-controlled parallel group clinical trial vs. cefuroxime and ambroxol.
    Matthys H; de Mey C; Carls C; Ryś A; Geib A; Wittig T
    Arzneimittelforschung; 2000 Aug; 50(8):700-11. PubMed ID: 10994153
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Randomised double blind placebo controlled clinical trial of sucralfate and ranitidine in chronic duodenal ulcer.
    Nair KV; Ramachandran TM; Thomas V; Rajindranath T
    J Assoc Physicians India; 1990 Mar; 38(3):211-2. PubMed ID: 2202705
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dyspepsia: Therapeutic response as a diagnostic tool.
    Petersen H; Løge I; Johannessen T; Fjøsne U; Kleveland PM; Kristensen P; Sandbakken P; Hafstad PE; Halvorsen T
    Scand J Gastroenterol Suppl; 1987; 128():108-13. PubMed ID: 3476994
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ulcer recurrence following duodenal ulcer healing with omeprazole, ranitidine, or placebo: a double-blind, multicenter, 6-month study. The Omeprazole Duodenal Ulcer Study Group.
    Graham DY; Colon-Pagan J; Morse RS; Johnson TL; Walsh JH; McCullough AJ; Marks JW; Sklar M; Stone RC; Cagliola AJ
    Gastroenterology; 1992 Apr; 102(4 Pt 1):1289-94. PubMed ID: 1551535
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.